Program -
Saturday, March 23, 2024
17:30 - 18:30
17:30 - 18:30
IDENTIFICATION OF MICRORNAS SIGNATURE PREDICTIVE OF SHORT AND LONG SURVIVAL IN GLIOBLASTOMA PATIENTS TREATED WITH TEMOZOLOMIDE
Oral Presentation
Presenter: Daniel Antunes Moreno
1 Barretos Cancer Hospital, Brazil
IN SILICO CHARACTERIZATION OF GBM SUBTYPES AND COMPUTATIONAL PREDICTION OF PHARMACOLOGICAL VULNERABILITIES
Oral Presentation
Presenter: Alberto Luigi Gallotti
1 Università degli Studi di Milano
2 San Raffaele Scientific Institute
MUTLIMODAL INTEGRATION OF TRANSCRIPTOMICS, PROTEOMICS AND RADIOMICS IMPROVES PREDICTION OF RECURRENCE IN PATIENTS WITH IDH-MUTANT GLIOMA
Oral Presentation
Presenter: Marco Rossi
1 University of Bordeaux, INSERM U1312 BRIC, 33600 Pessac, France
2 INRIA, University of Bordeaux Inria Monc, IMB, UMR 5251, 33400 Talence, France
3 University of Bordeaux, INSERM Bordeaux Population Health Research Center, SISTM team, UMR 1219, 146 rue Léo Saignat, Bordeaux France
4 Luxembourg Institute of Health, L-1445 Strassen, Luxembourg
5 Neurosurgical Oncology Unit, Dept of Medical Biotechnology and Translational Medicine, and IRCCS Galeazzi Sant’Ambrogio
6 Laboratoire de Biologie Computationnelle et Quantitative (LCQB), UMR 7238 CNRS, Université Sorbonne
7 Neurosurgical Oncology Unit, Dept of Oncology and Hemato-Oncology, Università degli Studi di Milano and IRCCS Galeazzi Sant’Ambrogio
8 Nuclear Medicine Unit, Humanitas Research Hospital
9 Pathology Unit, Humanitas Research Hospital
10 Department of Biomedicine, University of Bergen, Norway; KG Jebsen Brain TumorResearch Center, University of Bergen, Norway
11 CHU Pellegrin, Groupe Hospitalier Pellegrin, Place Amélie Raba Léon, Bordeaux, France 6 Neurosurgical Oncology Unit, Dept of Medical Biotechnology and Translational Medicine,